Action PBSV PHARMA-BIO SERV, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Pharma-Bio Serv, Inc.

Actions

PBSV

US71711N1000

Marché Fermé - OTC Markets
Autres places de cotation
 15:56:59 26/06/2024 		Varia. 5j. Varia. 1 janv.
0,648 USD +7,25 % Graphique intraday de Pharma-Bio Serv, Inc. -0,31 % -38,29 %
14/06 Pharma-Bio Serv, Inc. déclare ses résultats pour le deuxième trimestre et les six mois terminés le 30 avril 2024 CI
18/03 Pharma-Bio Serv, Inc. déclare ses résultats pour le premier trimestre terminé le 31 janvier 2024 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014.
Pharma-Bio Serv, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2024
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014.
Pharma-Bio Serv, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024
Pharma-Bio Serv Announces Full Year Results
Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About February 15, 2024
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014.
Pharma-Bio Serv, Inc. Reports Earnings Results for the Full Year Ended October 31, 2023
Pharma-Bio Serv, Inc. Approves Special Dividend, Payable on or About February 15, 2024
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014.
Pharma-Bio Serv, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014.
Pharma-Bio Serv, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023
PHARMA-BIO SERV, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
PHARMA-BIO SERV, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
PHARMA-BIO SERV, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014.
PHARMA-BIO SERV, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
Pharma-Bio Serv, Inc. Announces Special Dividend, Payable on or About April 14, 2023
PHARMA-BIO SERV, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action PBSV
  4. Actualités Pharma-Bio Serv, Inc.
  5. Autres langues